• 1
    Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents. vol. 7. Lyon: IARC, 1997. 3347.
  • 2
    King H, Haenszel K. Cancer mortality among foreign and naive-born Chinese in the United States. J Chronic Dis 1972; 26: 62346.
  • 3
    Buell P. The effect of migration on the risk of nasopharyngeal cancer among Chinese. Cancer Res 1974; 34: 118991.
  • 4
    Simons MJ, Shanmugaratnam K. The biology of nasopharyngeal carcinoma. UICC Technical Report Series. Volume 71. Geneva: UICC, 1982. 215.
  • 5
    Stinson WD. Epidermoid carcinoma of the nasopharynx occurring in two young brothers. Ann Otol 1940; 49: 5369.
  • 6
    Nevo S, Meyer W, Altman M. Carcinoma of nasopharynx in twins. Cancer 1971; 28: 8079.
  • 7
    Ho HC. Current knowledge of the epidemiology of nasopharyngeal carcinoma—a review. In: BiggsPM, de TheG, PayneLN, eds. Oncogenesis and herpesviruses. vol. 2. Lyon: IARC, 1972. 35766.
  • 8
    Brown TM, Heath CW, Lang RM, Lee SK, Whalley BW. Nasopharyngeal cancer in Bermuda. Cancer 1976; 37: 14648.
  • 9
    Lanier AP, Bender TR, Tschopp CF, Dohan P. Nasopharyngeal carcinoma in an Alaskan Eskimo family: report of three cases. J Natl Cancer Inst 1979; 62: 11214.
  • 10
    Yu MC, Garabrant DH, Huang TB, Henderson BE. Occupational and other non-dietary risk factors for nasopharyngeal carcinoma in Guangzhou, China. Int J Cancer 1990; 45: 10339.
  • 11
    Henle G, Henle W. Epstein-Barr virus specific IgA serum antibodies as an outstanding feature of in nasopharyngeal carcinoma. Int J Cancer 1976; 17: 117.
  • 12
    Ho JHC, Ng MH, Kwan HC, Chau JCW. Epstein-Barr virus specific antibodies in nasopharyngeal carcinoma patients and control. Br J Cancer 1976; 34: 65560.
  • 13
    Huang DP, Ho JHC, Henle W, Henle G, Saw D, Lui M. Presence of EBNA in NPC and control patient tissues related to EBV serology. Int J Cancer 1978; 22: 26674.
  • 14
    Ho JHC. Genetic and environmental factors in nasopharyngeal carcinoma. In: NakaharaW, NishiokaK, HirayamaT, eds. Recent advances in human tumor virology and immunology. Tokyo: University of Tokyo Press, 1971. 27595.
  • 15
    Armstrong RW, Armstrong MJ, Yu MC, Henderson B. Salted fish and inhalants as risk factors in nasopharyngeal carcinoma in Malaysian Chinese. Cancer Res 1983; 43: 296770.
  • 16
    Huang DP, Ho JHC. Salted fish and nasopharyngeal carcinoma. In: StichHF, ed. Carcinogen and mutagens in the environment naturally occurring compounds: epidemiology and distribution. Volume III. USA: CRC Press, 1983. 217.
  • 17
    Poirier S, Ohshima H, de The G, Hubert A, Bourgade MC, Bartsch H. Volatile nitrosamine levels in common food from Tunisia, South China, and Greenland, high risk areas for nasopharyngeal carcinoma (NPC). Int J Cancer 1987; 39; 2926.
  • 18
    Huang DP. Epidemiology of nasopharyngeal carcinoma. Ear Nose Throat J 1990; 69: 2225.
  • 19
    Yu MCC. Nasopharyngeal carcinoma: epidemiology and dietary factors. NUH-CME Rev 1993; 3: 926.
  • 20
    Doll R, Payne P, Waterhouse J. Cancer incidence in five continents. UICC Technical Report. Berlin: Springer Verlag, 1966.
  • 21
    Waterhouse J, Muir CS, Correa P, Powell J. Cancer incidence in five continents. vol. 3. Lyon: IARC, 1976. 2823.
  • 22
    Waterhouse J, Muir CS, Shanmugaratnam K, Powell J. Cancer incidence in five continents. vol. 4. Lyon: IARC, 1982. 3869.
  • 23
    Muir CS, Waterhouse J, Mack T, Powell J, Whelan SL. Cancer incidence in five continents. vol. 5. Lyon: IARC, 1987. 4025.
  • 24
    Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer incidence in five continents. vol. 7. Lyon: IARC, 1992. 4447.
  • 25
    Simons MJ, Chan SH, Wee GB, Shanmugaratnam K, Day NE, de The G. Probable identification of an HLA second locus antigen associated with a high risk of nasopharyngeal carcinoma. Lancet 1975; 8: 1423.
  • 26
    Chan SH, Day NE, Kunaratnam N, Chua KB, Simons MJ. HLA and nasopharyngeal carcinoma in Chinese—a further study. Int J Cancer 1983; 32: 1716.
  • 27
    Chan SH. Etiology of nasopharyngeal carcinoma. Ann Acad Med 1990; 19: 2017.
  • 28
    Burt RD, Vaughan TL, McKnight B, Davis S, Beckmann AM, Smith AG, Nisperos B, Swanson GM, Berwick M. Association between human leucocyte antigen type and nasopharyngeal carcinoma in Caucasians in United States. Cancer Epidemiol Biomarkers Prev 1996; 5: 87987.
  • 29
    Huang DP, Lo KW. Etiological factors and pathogenesis. In: van HasseltCA, GibbAG, eds. Nasopharyngeal carcinoma. 2nd ed. Hong Kong: Chinese University Press, 1999. 3160.
  • 30
    Meyer JE, Wang CC. Carcinoma of the nasopharynx: factors influencing results of therapy. Radiology 1971; 100: 3858.
  • 31
    Huang SC. Nasopharyngeal cancer: a review of 1605 patients treated radically with cobalt 60. Int J Radiat Oncol Biol Phys 1980; 6: 4017.
  • 32
    Neel HB, Taylor WF, Pearson GR. Prognostic determinants and a new view of staging for patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 1985; 94: 52937.
  • 33
    Qin D, Hu Y, Yan J, Xu G, Cai W, Wu X, Cao D, Gu X. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer 1988; 61: 111724.
  • 34
    Sham JST, Choy D. Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. Br J Radiol 1990; 63: 518.
  • 35
    Teo P, Yu P, Lee WY, Leung SF, Kwan WH, Yu KH, Choi P, Johnson PJ. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys 1996; 36: 291304.
  • 36
    Lee AWM, Foo W, Law SCK, Poon YF, Sze WM, O SK, Tung Y, Lau WH. Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. Hong Kong Med J 1997; 3: 35561.
  • 37
    Lee AWM, Ko WM, Foo W, Choi P, Tung Y, Sham J, Cheng B, Au G, Lau WH, Choy D, O SK, Sze WM, et al. Nasopharyngeal carcinoma: time lapse before diagnosis and treatment. Hong Kong Med J 1998; 4: 1326.
  • 38
    Lee AWM, Poon YF, Foo W, Law SCK, Cheung FK, Chan DKK, O SK, Tung SY, Myo T, Ho JHC. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992; 23: 26170.